MRC1 and endometrium neoplasm: Somatic acquired alterations, such as MLH1 promoter CpG island methylation and biallelic somatic mutations in the MMR genes are increasingly being used to identify so-called spontaneous MMR deficient colorectal and endometrial tumours [19,20,21,22,23,24,25].